G2019SLRRK2I:

Avigyan Naskar1, Kousik K Bhanja1, Rakesh K Roy1

  • 1Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad, India.

概括

这项研究比较了与野生类型和突变LRRK2激酶结合的五种抑制剂,发现像MLi-2这样的大分子对G2019SLRRK2具有选择性,有助于帕金森氏症.